115 related articles for article (PubMed ID: 410296)
1. Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix.
Piver MS; Barlow JJ; Vongtama V; Blumenson L
Am J Obstet Gynecol; 1977 Oct; 129(4):379-83. PubMed ID: 410296
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study.
Piver MS; Barlow JJ; Vongtama V; Blumenson L
Am J Obstet Gynecol; 1983 Dec; 147(7):803-8. PubMed ID: 6359885
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer.
Piver MS; Vongtama V; Emrich LJ
J Surg Oncol; 1987 Jun; 35(2):129-34. PubMed ID: 3108586
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
Stehman FB; Bundy BN; Keys H; Currie JL; Mortel R; Creasman WT
Am J Obstet Gynecol; 1988 Jul; 159(1):87-94. PubMed ID: 3293456
[TBL] [Abstract][Full Text] [Related]
5. Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea.
Piver MS; Krishnamsetty RM; Emrich LJ
Am J Obstet Gynecol; 1985 Apr; 151(8):1006-8. PubMed ID: 3985061
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage IIIB cervical cancer.
Piver M; Khalil M; Emrich LJ
J Surg Oncol; 1989 Oct; 42(2):120-5. PubMed ID: 2796346
[TBL] [Abstract][Full Text] [Related]
7. Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix.
Stehman FB
Semin Oncol; 1992 Jun; 19(3 Suppl 9):48-52. PubMed ID: 1641657
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea and radiation therapy in advanced cervical cancer.
Piver MS; Barlow JJ; Vongtama V; Webester J
Am J Obstet Gynecol; 1974 Dec; 120(7):969-72. PubMed ID: 4279553
[No Abstract] [Full Text] [Related]
9. Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery.
Fine BA; Hempling RE; Piver MS; Baker TR; McAuley M; Driscoll D
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):717-23. PubMed ID: 7860382
[TBL] [Abstract][Full Text] [Related]
10. [Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma].
Nöel G; Mazeron JJ
Cancer Radiother; 1999; 3(4):345-7. PubMed ID: 10515699
[No Abstract] [Full Text] [Related]
11. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
Husseinzadeh N; Shrake P; DeEulis T; Rowley K; Aron B
Gynecol Oncol; 1994 Mar; 52(3):326-31. PubMed ID: 8157190
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis.
Hreshchyshyn MM; Aron BS; Boronow RC; Franklin EW; Shingleton HM; Blessing JA
Int J Radiat Oncol Biol Phys; 1979 Mar; 5(3):317-22. PubMed ID: 110744
[No Abstract] [Full Text] [Related]
15. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
[TBL] [Abstract][Full Text] [Related]
16. Adriamycin and hydroxyurea as radiopotentiators in the treatment of squamous cell carcinoma of the cervix implanted in nude mice: a preliminary report.
Xynos FP; Benjamin I; Sapiente R; Rana MW; Nalesnik WJ
Gynecol Oncol; 1980 Apr; 9(2):170-6. PubMed ID: 7372189
[No Abstract] [Full Text] [Related]
17. Laparoscopic lymphadenectomy in advanced cervical cancer: prognostic and therapeutic value.
Del Pino M; Fusté P; Pahisa J; Rovirosa A; Martínez-Serrano MJ; Martínez-Román S; Alonso I; Vidal L; Ordi J; Torné A
Int J Gynecol Cancer; 2013 Nov; 23(9):1675-83. PubMed ID: 24172103
[TBL] [Abstract][Full Text] [Related]
18. Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review.
Symonds RP; Collingwood M; Kirwan J; Humber CE; Tierney JF; Green JA; Williams C
Cancer Treat Rev; 2004 Aug; 30(5):405-14. PubMed ID: 15245773
[TBL] [Abstract][Full Text] [Related]
19. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
[TBL] [Abstract][Full Text] [Related]
20. Current concepts in cancer: updated cervix cancer III. Stages III and IV. Combination chemotherapy and radiation therapy.
Jones TK; Levitt SH
Int J Radiat Oncol Biol Phys; 1979; 5(11-12):2147-9. PubMed ID: 397212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
